David R. Sibley

Statistics

Publications

191

Citations

20.6K

H-Index

Active since

1979

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

National Institutes of Health

National Institute of Mental Health

Rosalind Franklin University of Medicine and Science

National Institute on Drug Abuse

David R. Sibley is an author at National Institute of Neurological Disorders and Stroke specializing in neuropharmacology, life sciences, and dopamine receptor subtypes.

ORCID

Publications per year

1979–2024

191

Publications

191

D <sub>1</sub> and D <sub>2</sub> Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons

Charles R. Gerfen, Thomas M. Engber, Lawrence C. Mahan et al. · Science · 1990 · 3K citations

Life Sciences, Neurobiology, Neuroscience +17

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

Sean M Renock, Elaine G. Arrington, Louis A. Chiodo et al. · Neuropsychopharmacology · 2003 · 974 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Multiple D2 dopamine receptors produced by alternative RNA splicing

Frederick J. Monsma, Loris D. McVittie, Charles R. Gerfen et al. · Nature · 1989 · 645 citations

Life Sciences, Molecular Biology, Neuroscience +13

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

Frederick J. Monsma, Yong Shen, Raymond P. Ward et al. · Molecular Pharmacology · 1993 · 598 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

M. Salman Choudhary, Sean C. Craigo, David R. Sibley et al. · UNC Libraries · 2019 · 595 citations · Full text

Medicine, Pharmacology, Psychiatry +13

1–5 of 191